Adverse Events Module
For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
Adverse Events Module
Event Groups
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Three Treatments in Random Order | Each participant will receive a single dose of lithyronine, a single dose of levothyroxine, and a single dose of placebo, in a random order. Information on the order of treatments was not collected. Participants will attend three study visits. At the first study visit one of the three treatments will be randomly selected and administered. At the second study visit one of the remaining two treatments will be randomly selected and administered. At the third study visit the final treatment will be administered. The order of administration will not be tracked. | 0 | None | 0 | 12 | 0 | 12 | View |